Former President Donald Trump's political campaign is facing financial hurdles as it struggles to keep pace with President Joe Biden's strong financial position.
read more
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
The board of Tesla Inc. (NASDAQ: TSLA) is struggling to maintain CEO Elon Musk's total commitment while he manages multiple ventures.
read more
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
A poll by Bloomberg/Morning Consult reveals a surprising preference among Americans for former President Donald Trump over President Joe Biden concerning the economy, despite more robust economic …
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
Stock markets worldwide are reaching record-breaking highs. This unprecedented rally, spanning from Tokyo to New York, has seen 14 of the world's 20 largest stock markets hit all-time highs.
read …
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
Robert Hale Jr., the CEO of Granite Telecommunications, surprised graduating students on Thursday. Each student received two $500 payments.
more
Lauren Edmonds (via Business Insider)
|
5/18/24
|
The first person in line for Trump's Manhattan trial on Wednesday morning paid $1,800 for someone to keep their spot, NBC News reported.
more
Cameron Manley (via Business Insider)
|
5/18/24
|
A transfer of 120 million Dogecoin (CRYPTO: DOGE) to the trading platform Robinhood has coincided with a 4.45% surge in the price of the meme crypt
read more
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
A new poll by Yahoo News/YouGov shows that a potential rematch between President Joe Biden and former President Donald Trump is still a close call. Both candidates are tied at 45% among registered …
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
Former President Donald Trump has called for President Joe Biden to undergo a drug test ahead of their debates scheduled for June and September.
read more
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
Elon Musk recently expressed his views on drug use and its potential benefits on X, sparking a flurry of reactions.
read more
more
Bibhu Pattnaik (via Benzinga)
|
5/18/24
|
Anthony Scaramucci has characterized the ongoing Donald Trump hush money trial as a test of loyalty for Republican officials.
read more
more
Rounak Jain (via Benzinga)
|
5/18/24
|
Crockett accuses Greene of racism over fake eyelashes taunt during a hearing. Crockett says Greene has not attacked other colleagues' appearances.
read more
more
Rounak Jain (via Benzinga)
|
5/18/24
|
Biden's praise for his economic policies contrasts sharply with voter perceptions, a report says.
read more
more
Shanthi Rexaline (via Benzinga)
|
5/18/24
|
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).
read more
more
Nicolás Jose Rodriguez (via Benzinga)
|
5/18/24
|
The next market rotation could be into insurance stocks and they could rally as much as 30%, according to an investment advisor.
read more
more
Shanthi Rexaline (via Benzinga)
|
5/18/24
|
Watch the online edition of Global News Hour at 6 BC.
more
Via Global News
|
5/17/24
|
read more
more
Benzinga Insights (via Benzinga)
|
5/17/24
|
read more
more
Benzinga Insights (via Benzinga)
|
5/17/24
|
read more
more
Benzinga Insights (via Benzinga)
|
5/17/24
|
read more
more
Benzinga Insights (via Benzinga)
|
5/17/24
|
Michael Berger, founder of Technical420, managing partner of StoneBridge Partners and the beloved maven behind Benzinga Cannabis Research, our cannabis stock analysis and trading subscriber-only …
more
Javier Hasse (via Benzinga)
|
5/17/24
|
Microchip Technology (NASDAQ: MCHP) is expanding its footprint in the aerospace and defense industry by introducing the SAMD21RT, a radiation-tolerant 32-bit microcontroller (MCU) based on the Arm …
more
Zacks (via Benzinga)
|
5/17/24
|
Inflation has been a major concern lately as uncertainty has been growing over the Federal Reserve's timing of rate cuts. However, much to consumers' relief, inflation finally eased in April after …
more
Zacks (via Benzinga)
|
5/17/24
|
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced their decision to terminate the development of their …
more
Zacks (via Benzinga)
|
5/17/24
|
The Zacks Tobacco industry players have been witnessing soft cigarette sales volumes due to inflation, changing consumer habits, and stringent regulations. Increased costs of essential materials …
more
Zacks (via Benzinga)
|
5/17/24
|